Kite’s CAR T-Cell Therapy Success – The Scientist
The Scientist |
Kite’s CAR T-Cell Therapy Success
The Scientist CAR T cell success in lymphoma Follicular lymphoma in bone marrowFLICKR, ED UTHMANSix months after receiving infusions of their own T cells—genetically engineered ex vivo to carry chimeric antigen receptors (CAR) that bind to proteins on the surface … With Eye On FDA, Kite Says CAR–T For Lymphoma Holds Up After 6 MonthsXconomy Kite’s CAR–T cancer therapy shows strong results as company races to win FDA approvalSTAT Kite Pharma CAR–T Cancer Therapy Shows Strong, Durable Effect in Lymphoma PatientsTheStreet.com Healio –Telegraph.co.uk –CNBC all 98 news articles » |
Mirror.co.uk |
Leukaemia sufferer whose sister was refused visa to give her stem cell transplant has finally had lifesaving op
Mirror.co.uk A woman who feared for her life after her sister was refused a visa to give her a stem cell transplant has finally undergone the operation. May Brown, 23, who has leukaemia , hit the headlines last year after pleading with the Home Office to allow her … May Brown: Transplant success for visa battle sistersBBC News Transplant recipient: ‘I prepared myself for death’ITV News |
|
New Report Highlights Limitations of Immunotherapy for Mesothelioma
Benzinga “Although some of the more recent studies of CTLA-4 inhibitors for mesothelioma have tempered some of the initial excitement, immunotherapy still holds a great deal of promise as part of a combination approach,” says Alex Strauss, Managing Editor for … |
|
New Report Highlights Limitations of Immunotherapy for Mesothelioma
Benzinga “Although some of the more recent studies of CTLA-4 inhibitors for mesothelioma have tempered some of the initial excitement, immunotherapy still holds a great deal of promise as part of a combination approach,” says Alex Strauss, Managing Editor for … |